Search - tctmd.com

Displaying 221 - 240 of 324

Presentation TVT 2017

CARILLON: Eligibility and Outcomes, and RCT Design

Presenter: Saibal Kar, Steven L. Goldberg, MD

June 15, 2017

$Tricuspid Sapien 3 Valve in Incomplete Ring Followed by ASO Closure of Severe PVL for Severe TR and Refractory Right Sided Heart Failure$

Presentation TVT 2017

Tricuspid Sapien 3 Valve in Incomplete Ring Followed by ASO Closure of Severe PVL for Severe TR and Refractory Right Sided Heart Failure

Presenter: Azeem Latib, Christopher U. Meduri, Elliott Groves, MD

June 15, 2017

News Daily News

Educational Attainment Inversely Associated With Lifetime Risk of CVD

Ashley Lyles

June 15, 2017

Presentation TVT 2017

Impact of Valvular Heart Disease on the Global Burden of Heart Failure: Can Transcatheter Therapies Make a Difference?

Presenter: Mark Reisman, Gregg W. Stone, Clyde W. Yancy

June 15, 2017

Podcast TCTMD Talking Points

Episode 22: The A-fib and ACS Overlap

June 14, 2017

News Daily News

Traditional Chinese Medicine May Aid in Prevention of Cardiovascular Disease

L.A. McKeown

June 12, 2017

News Conference News TVT 2017

Q&A: Transcatheter Valve Innovation Past, Present, and Future as TVT Turns 10

Shelley Wood

June 12, 2017

News Daily News

HeartMate II Left Ventricular Assist System Under Recall Due to Controller Exchange Problems

Todd Neale

May 24, 2017

News Daily News

Triple Therapy Not Being Widely Used in A-fib Patients Undergoing PCI

L.A. McKeown

May 23, 2017

News Daily News

Anabolic Steroid Use Linked With Myocardial Dysfunction and Accelerated Atherosclerosis

Alison Palkhivala

May 23, 2017

News Industry News

Medtronic RESOLUTE ONYX(TM) 2.0 mm Clinical Study Meets Primary Endpoint in Extra-Small Vessels at One-Year

May 18, 2017

News Conference News EuroPCR 2017

TAVR Durability: Some Reassurances From CoreValve Trials Out to 9 Years

Caitlin E. Cox

May 17, 2017

News Conference News EuroPCR 2017

If They Survive First Month, Mitral Annular Calcification Patients Treated With Transcatheter Valves Do Well at 1 Year

Shelley Wood

May 17, 2017

No Very Late Scaffold Thrombosis Risk With Absorb BVS in China, Japan

News Conference News EuroPCR 2017

No Very Late Scaffold Thrombosis Risk With Absorb BVS Studies in China, Japan

Michael O'Riordan

May 17, 2017

News Industry News

Micell Technologies Announces MiStent Achieved Primary Endpoint in All-Comers Randomized Clinical Trial Versus Xience

May 16, 2017

News Conference News EuroPCR 2017

Big Questions for Bioresorbable Scaffolds: Experts and Innovators Debate

Michael O'Riordan

May 15, 2017

News Conference News SCAI 2017

Bioresorbable Scaffolds: Where Do We Go From Here?

L.A. McKeown

May 15, 2017

News Conference News EuroPCR 2017

EuroPCR 2017: New Stents, New Questions for PCI Today and Tomorrow as Angioplasty Turns 40

Shelley Wood

May 12, 2017

News Industry News

Medtronic First to Receive FDA Approval for MR-Conditional Quadripolar Cardiac Resynchronization Therapy-Pacemakers

May 11, 2017

News Daily News

Rivaroxaban Appears to Protect Against MI in Older Men With A-fib, but Not in Women

Todd Neale

May 11, 2017

Advertisement

CARILLON: Eligibility and Outcomes, and RCT Design

Tricuspid Sapien 3 Valve in Incomplete Ring Followed by ASO Closure of Severe PVL for Severe TR and Refractory Right Sided Heart Failure

Educational Attainment Inversely Associated With Lifetime Risk of CVD

Impact of Valvular Heart Disease on the Global Burden of Heart Failure: Can Transcatheter Therapies Make a Difference?

Episode 22: The A-fib and ACS Overlap

Traditional Chinese Medicine May Aid in Prevention of Cardiovascular Disease

Q&A: Transcatheter Valve Innovation Past, Present, and Future as TVT Turns 10

HeartMate II Left Ventricular Assist System Under Recall Due to Controller Exchange Problems

Triple Therapy Not Being Widely Used in A-fib Patients Undergoing PCI

Anabolic Steroid Use Linked With Myocardial Dysfunction and Accelerated Atherosclerosis

Medtronic RESOLUTE ONYX(TM) 2.0 mm Clinical Study Meets Primary Endpoint in Extra-Small Vessels at One-Year

TAVR Durability: Some Reassurances From CoreValve Trials Out to 9 Years

If They Survive First Month, Mitral Annular Calcification Patients Treated With Transcatheter Valves Do Well at 1 Year

No Very Late Scaffold Thrombosis Risk With Absorb BVS Studies in China, Japan

Micell Technologies Announces MiStent Achieved Primary Endpoint in All-Comers Randomized Clinical Trial Versus Xience

Big Questions for Bioresorbable Scaffolds: Experts and Innovators Debate

Bioresorbable Scaffolds: Where Do We Go From Here?

EuroPCR 2017: New Stents, New Questions for PCI Today and Tomorrow as Angioplasty Turns 40

Medtronic First to Receive FDA Approval for MR-Conditional Quadripolar Cardiac Resynchronization Therapy-Pacemakers

Rivaroxaban Appears to Protect Against MI in Older Men With A-fib, but Not in Women

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content